FHL1 activates myostatin signalling in skeletal muscle and promotes atrophy

Lee, J Y; Lori, D; Wells, D J; Kemp, P R

Abstract

Myostatin is a TGFβ family ligand that reduces muscle mass. In cancer cells, TGFβ signalling is increased by the protein FHL1. Consequently, FHL1 may promote signalling by myostatin. We therefore tested the ability of FHL1 to regulate myostatin function. FHL1 increased the myostatin activity on a SMAD reporter and increased myostatin dependent myotube wasting. In mice, independent expression of myostatin reduced fibre diameter whereas FHL1 increased fibre diameter, both consistent with previously identified effects of these proteins. However, co‐expression of FHL1 and myostatin reduced fibre diameter to a greater extent than myostatin alone. Together, these data suggest that the expression of FHL1 may exacerbate muscle wasting under the appropriate conditions.

Citation

Lee, J. Y., Lori, D., Wells, D. J., & Kemp, P. R. (2015). FHL1 activates myostatin signalling in skeletal muscle and promotes atrophy. FEBS Open Bio, 5, 753-762. https://doi.org/10.1016/j.fob.2015.08.011

• Journal Article Type: Article
• Acceptance Date: Aug 25, 2015
• Publication Date: Sep 1, 2015
• Deposit Date: Nov 19, 2015
• Publicly Available Date: Jan 23, 2019
• Journal: FEBS Open Bio
• Publisher: Elsevier
• Peer Reviewed: Peer Reviewed
• Volume: 5
• Pages: 753-762
• DOI: https://doi.org/10.1016/j.fob.2015.08.011
• Public URL: https://rvc-repository.worktribe.com/output/1399823